Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
33(7):1752-68
The pharmacology of TUG-891
MRI Determination of the Mechanisms Underlying TNF-a-induced Changes in Cerebral Blood Volume
24 hours) reduces the expression of GPX4 protein
Atenolol Catalog No.:M8489-2 33(7):1752-68Atenolol is a selective 1 receptor antagonist. It belongs to the group of beta blockers (sometimes written blockers), a class of drugs used primarily in cardiovascular diseases. Atenolol was developed as a replacement for propranolol in the treatment of hypertension. It works by slowing down the heart and reducing its workload. Unlike propranolol, atenolol does not pass through the bloodbrain barrier to a large extent thus decreasing the incidence of
US$ 850.00
US$ 600.00
US$ 1300.00
US$ 600.00
US$ 600.00
US$ 700.00
US$ 1400.00
US$ 390.00